BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/12/2020 9:10:19 AM | Browse: 799 | Download: 982
 |
Received |
|
2020-01-21 16:44 |
|
Peer-Review Started |
|
2020-01-21 16:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-03-05 22:04 |
|
Revised |
|
2020-05-16 03:43 |
|
Second Decision |
|
2020-07-31 09:34 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-08-01 21:27 |
|
Articles in Press |
|
2020-08-01 21:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-08-05 01:05 |
|
Publish the Manuscript Online |
|
2020-08-12 09:10 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sakti Chakrabarti, Carrie Y Peterson, Deepika Sriram and Amit Mahipal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sakti Chakrabarti, MD, Associate Professor, Division of Hematology/Oncology, Medical College of Wisconsin, No. 8701, Watertown Plank Road, Milwaukee, WI 53226, United States. schakrabarti@mcw.edu |
| Key Words |
Adjuvant; Circulating tumor DNA; Immunoscore; Minimally invasive; Neoadjuvant; FOxTROT |
| Core Tip |
Although the majority of patients with colon cancer are diagnosed in an early stage, cancer recurrence after initial curative therapy is frequent, underscoring the need for novel approaches. The challenges in the current treatment paradigm include the lack of precise patient selection tools for adjuvant therapy, disabling toxicities, and modest efficacy of the adjuvant therapies. Herein we provide a contemporaneous appraisal of the early stage colon cancer treatment and discuss how evolving technologies, including circulating tumor DNA, can potentially transform the standard of care. |
| Publish Date |
2020-08-12 09:10 |
| Citation |
Chakrabarti S, Peterson CY, Sriram D, Mahipal A. Early stage colon cancer: Current treatment standards, evolving paradigms, future directions. World J Gastrointest Oncol 2020; 12(8): 808-832 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i8/808.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i8.808 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
